Your browser doesn't support javascript.
loading
Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study.
Schneider, Andrea L C; Zhao, Di; Lutsey, Pamela L; Gottesman, Rebecca F; Sharrett, A Richey; Rawlings, Andreea M; Alonso, Alvaro; Knopman, David; Mosley, Thomas H; Selvin, Elizabeth; Michos, Erin D.
Afiliación
  • Schneider ALC; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USAachris13@jhmi.edu.
  • Zhao D; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Lutsey PL; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Gottesman RF; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Sharrett AR; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Rawlings AM; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Alonso A; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Knopman D; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
  • Mosley TH; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Selvin E; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Michos ED; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Neuroepidemiology ; 51(3-4): 131-137, 2018.
Article en En | MEDLINE | ID: mdl-30092587
BACKGROUND/AIMS: 25-hydroxyvitamin D (25[OH]D) concentrations have been associated with cognitive decline and incident dementia in elderly populations; however, these relationships are susceptible to reverse causation. Less is known about the association of midlife 25(OH)D with long-term cognitive decline. METHODS: This was a prospective cohort study of 13,044 participants (mean age 57 years at baseline) in the Atherosclerosis Risk in Communities Study. 25(OH)D was measured from serum collected at baseline (1990-1992) using liquid chromatography tandem high-sensitivity mass spectrometry. Cognition was assessed using 3 neuropsychological tests at 3 time points, which were combined into a composite cognitive Z-score. Multivariable-adjusted linear mixed-effects models with random intercepts and slopes were used to estimate associations between 25(OH)D and cognitive change over 20 years. RESULTS: Compared to persons with sufficient 25(OH)D (≥30 ng/mL), those with deficient (< 20 ng/mL) and intermediate (20-< 30 ng/mL) 25(OH)D concentrations had similar cognitive decline in composite cognitive Z-scores (deficient versus sufficient: -0.035 [95% CI -0.104 to 0.033] and intermediate versus sufficient: -0.029 [95% CI -0.080 to 0.023]). CONCLUSIONS: Lower concentrations of 25(OH)D measured in midlife were not significantly associated with more rapid cognitive decline over a 20-year follow-up period. The results of this prospective study are less susceptible to reverse causation than prior studies.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vitamina D / Cognición / Aterosclerosis / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroepidemiology Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vitamina D / Cognición / Aterosclerosis / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroepidemiology Año: 2018 Tipo del documento: Article